Tribunal upholds ₹5.4cr ED attachment on Lucent Drugs
The story in brief
The Appellate Tribunal under SAFEMA Act upheld the Enforcement Directorate’s attachment of ₹5.46 crore from Lucent Drugs Pvt Ltd for unauthorised tramadol exports to Pakistan. The tribunal rejected the company’s valuation argument and dismissed its appeal, confirming the ED’s provisional attachment. The case began with an NCB complaint filed in 2022.